Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab... see more

TSX:MBX - Post Discussion

Microbix Biosystems Inc. > 2.8 Million Stock Options on Heels of Q1 Bomb
View:
Post by tulipbubble on Mar 01, 2023 5:19pm

2.8 Million Stock Options on Heels of Q1 Bomb

2.8 million options (without saying how many went to C-suite execs and the Board) on the heels of a huge revenue miss and big swing to cash losses is unethical and telling.  These never should have been "awarded".  At best deferred until a return to profitbability and market prices for the shares that reflect that after the Q1 bomb.   

Dec 22  2022 Press Release about Record Sales and Profits:

"Corporate Outlook Microbix will continue to drive sales growth across all of its three revenue-generating business lines, and work to keep improving percentage gross margins and driving bottom-line results."  

At Dec 22/22 they had to know Q1 was looking to be a big miss.   Read the long explanations now being given for the miss...the Q1 bomb was no big surprise to Mgmt or the Board when they made the fwd looking comment above.  
Comment by rjc7 on Mar 01, 2023 6:24pm
Get over it. So they had a bad Q. The MBX of today is nothing like the losing MBX of years ago when all they had for product was low margin antigens. Every Q suffered huge losses back then. Far better to issue stock than increase salary for staff especially when inflation is running at 6.5%. If you don't help recoup some of the inflationary costs to your employees they will walk. Holding on to ...more  
Comment by tulipbubble on Mar 02, 2023 11:57am
"Get over it" 'cause they used to be worse? ...there's some sound advice.    How about reflecting on (A) the CEO is paid in cash about $360,000/yr; (B) the other C-suiters seem well paid for a pretty small company (see the AIF for their comp); and (C) the MBX option prctice is that 2/3rds of options "awarded" go to Directors and the Senior officers.  & ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities